[1]赵佳晖,姜永光,侯铸,等.经尿道前列腺电切术治疗合并冠脉支架的前列腺增生患者的临床经验[J].中华腔镜泌尿外科杂志(电子版),2017,11(02):101-104.[doi:10.3877/cma.j.issn.1674-3253.2017.02.006 ]
 Zhao Jiahui,Jiang Yongguang,Hou Zhu,et al.Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent[J].,2017,11(02):101-104.[doi:10.3877/cma.j.issn.1674-3253.2017.02.006 ]
点击复制

经尿道前列腺电切术治疗合并冠脉支架的前列腺增生患者的临床经验()
分享到:

中华腔镜泌尿外科杂志(电子版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
11
期数:
2017年02期
页码:
101-104
栏目:
临床研究
出版日期:
2017-04-30

文章信息/Info

Title:
Clinical experiences of summary of transurethral resection of prostate for begign prostatic hyperplasia with coronary stent
作者:
赵佳晖姜永光侯铸彭涛王永兴罗勇李明川
100029 北京,首都医科大学附属北京安贞医院泌尿外科
Author(s):
Zhao Jiahui Jiang Yongguang Hou Zhu Peng tao Wang Yongxing Luo Yong Li Mingchuan .
Department of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
关键词:
前列腺增生冠脉支架前列腺切除术
DOI:
10.3877/cma.j.issn.1674-3253.2017.02.006
摘要:
目的总结既往行冠脉支架植入的前列腺增生患者行经尿道前列腺电切术(TURP)手术的临床资料和治疗经验。方法回顾性分析首都医科大学附属北京安贞医院 2010至 2015年间合并冠心病既往行冠状动脉支架植入的前列腺增生患者 56例,年龄 57~86岁,平均 72岁。所有患者经充分术前准备,评估手术麻醉等风险,调整血压、改善心功能、停用抗凝药物,行 TURP手术。结果所有患者均安全度过围手术期,手术均获成功,未发生心脑血管意外及严重并发症,无死亡病例。国际前列腺症状评分 (IPSS)由术前(26±5)分降至术后(12±5)分,生活质量评分 (QOL)由术前(5.1±0.8)分降至术后(1.9±1.1)分,差异具有统计学意义(P<0.01)。结论对于合并冠状动脉支架的前列腺增生患者,进行充分的术前准备及围手术期治疗,TURP手术是一个安全有效的手术治疗方法。

参考文献/References:

[1] Gyomber D, Lawrentschuk N, Ranson DL, et al. An analysis of deaths related to urological surgery, reviewed by the State Coroner: a case for cardiac vigilance before transurethral prostatectomy[J]. BJU Int, 2006, 97(4): 758-761.
[2] Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation [J]. J Am Coll Cardiol, 2005, 45(6): 947-953.
[3] de la Torre-Hernández JM, Alfonso F, Hernández F, et al.Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpa? ol sobre TROmbosis de stents FArmacoactivos)[J]. J Am Coll Cardiol, 2008, 51 (10):986-990.
[4] Murray J, Saxena S, Millett C, et al. Reductions in risk factors for secondary prevention of coronary heart disease by ethnic group in south-west London: 10-year longitudinal study (1998-2007) [J]. Fam Pract, 2010, 27(4): 430-438.
[5] Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis [J]. J Intern Med, 2005,257(5): 399-414.
[6] Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease[J]. Eur Heart J, 2006, 27(22): 2667-2674.
[7] Donat R, Wilson I, Raza A, et al. A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP) [J]. J Urol, 2003,169(2): 466-467.
[8] Taylor K, Filgate R, Guo DY, et al. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs [J]. BJU Int, 2011,108(2): 45-50.
[9] Wenders M, Wenzel O, Nitzke T, et al. Perioperative platelet inhibition in transurethral interventions: TURP/TURB[J]. Int Braz J Urol, 2012, 38(5): 606-610.
[10] Nielsen JD, Holm-Nielsen A, Jespersen J, et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study [J]. Scand J Urol Nephrol, 2000, 34(3):194-198.
[11] Enver MK, Hoh I, Chinegwundoh FI. The management of aspirin in transurethral prostatectomy: current practice in the UK [J]. Ann R Coll Surg Engl, 2006, 88(3): 280-283.
[12] 杨毅, 陈荣, 吴德锋, 等. 经尿道前列腺电切术术前停服阿司匹林的时机选择[J]. 浙江实用医学, 2015, 20(3): 201-203.
[13] 袁渊, 姚启盛, 王晓康, 等. 高龄前列腺增生患者合并心血管疾病的围手术期处理[J]. 中华腔镜泌尿外科杂志:电子版, 2013, 7(1): 25-28.
[14] Rubino AS, Della Corte A, Giordano R, et al. Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting[J]. Eur J Cardiothorac Surg, 2014,46(2): 335.
[15] Ong WL, Koh TL, Fletcher J, et al. Perioperative management of antiplatelets and anticoagulants among patients undergoing elective transurethral resection of the Prostate--A single institution experience[J]. J Endourol, 2015, 29(11): 1321-1327.

相似文献/References:

[1]邓立文,涂响安,邓春华.经尿道前列腺电切术后谵妄诊治的临床分析[J].中华腔镜泌尿外科杂志(电子版),2008,(02):118.
 DENG Li-wen,TU Xian-gan,DENG Chun-hua.Clinical analysis of postoperative delirium in transurethral resection of the prostate[J].,2008,(02):118.
[2]王亮,李黎明,崔喆,等.经尿道前列腺等离子双极电切术与普通电切术中失血量比较[J].中华腔镜泌尿外科杂志(电子版),2009,(01):11.
 WANG Liang,LI Li-ming,CUI Zhe,et al.Blood loss comparison of transurethral plasmakinetic resection versus conventional transurethral resection of the prostate[J].,2009,(02):11.
[3]杨德林,柯昌兴,王剑松,等.等离子电切术中不同方法治疗前列腺增生症(附1900例报告)[J].中华腔镜泌尿外科杂志(电子版),2009,(01):37.
 YANG De-lin,KE Chang-xing,WANG Jian-song,et al.Various methods of transurethral plasmakinetic resection of prostate for the treatment of BPH ( Report of 1900 cases)[J].,2009,(02):37.
[4]何志新,温天奋,彭晓东,等.经尿道前列腺汽化电切术治疗前列腺增生症[J].中华腔镜泌尿外科杂志(电子版),2009,(04):309.
[5]李方,徐友明,刘进,等.膀胱颈切开防止小体积前列腺汽化电切术后膀胱颈挛缩的回顾研究[J].中华腔镜泌尿外科杂志(电子版),2009,(06):508.
 LI Fang,XU You-ming,LIU Jin,et al.Compare the contracture of the bladder neck after TUVP with bladder neck incision or not in patients with small prostate: a retrospective study[J].,2009,(02):508.
[6]杨志国,赵海东,刘永江,等.急诊经尿道前列腺电切治疗良性前列腺增生并急性尿潴留[J].中华腔镜泌尿外科杂志(电子版),2010,(01):46.
 YANG Zhi-guo,ZHAO Hai-dong,LIU Yong-jiang,et al.Transurethral resection of the prostate as emergency surgery for the treatment of BPH with acute urinary retention[J].,2010,(02):46.
[7]宋金亮,张斌.经尿道前列腺等离子电切术治疗合并糖尿病的良性前列腺增生症[J].中华腔镜泌尿外科杂志(电子版),2010,(01):69.
[8]王玉亭,李金海.前列腺汽化电切术后出血原因及治疗对策分析[J].中华腔镜泌尿外科杂志(电子版),2010,(03):204.
 WANG Yu-ting,LI Jin-hai.Analysis of the reasons and treatments of bleeding after tranurethral vaporization of the prostate[J].,2010,(02):204.
[9]彭明栋,陈永生,陈云峰,等.经尿道双极等离子体电切治疗高危前列腺增生症:附200例报告[J].中华腔镜泌尿外科杂志(电子版),2010,(03):211.
 PENG Ming-dong,CHEN Yong-sheng,CHEN Yun-feng,et al.Bipolar plasma kinetic resection of the prostate for the treatment of benign prostatic hyperplasia in the patients with high risk: a report of 200 cases[J].,2010,(02):211.
[10]程书栋,王慕华,王建文,等.经尿道双极等离子前列腺腔内剜除术治疗前列腺增生220例临床疗效分析[J].中华腔镜泌尿外科杂志(电子版),2010,(05):380.
 CHEN Shu-dong,WANG Mu-hua,WANG Jian-wen,et al.Bipolar plasmakinetic transurethral enucleation of prostate in the treatment of benign prostatic hyperplasia: Report of 220 cases[J].,2010,(02):380.
[11]宋金亮,张斌.冠脉支架术后患者的经尿道前列腺等离子电切术[J].中华腔镜泌尿外科杂志(电子版),2011,(04):290.
 SONG Jin-liang,ZHANG Bin.Transurethral plasmakinetic prostatectomy in the treatment of prostatic hyperplasia patients with coronary stent[J].,2011,(02):290.

备注/Memo

备注/Memo:
基金项目:北京市卫生系统高层次卫生技术人才学科带头人培养基金(2013-2-003)
通讯作者:赵佳晖,Email:jiahuizhao@163.com
更新日期/Last Update: 2017-04-20